Fifth Third Bancorp’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
20,802
+20,363
+4,638% +$2.66M ﹤0.01% 1201
2025
Q4
$53.4K Buy
439
+182
+71% +$22.8K ﹤0.01% 1436
2025
Q3
$28.8K Buy
257
+21
+9% +$2.46K ﹤0.01% 1738
2025
Q2
$31.6K Sell
236
-14
-6% -$1.54K ﹤0.01% 1603
2025
Q1
$16.8K Buy
250
+103
+70% +$7.08K ﹤0.01% 1828
2024
Q4
$9.16K Sell
147
-353
-71% -$32.9K ﹤0.01% 2001
2024
Q3
$78.5K Buy
+500
New +$77K ﹤0.01% 1258

Other funds holding TMDX

Fifth Third Bancorp's TMDX Position: Q1 2026 in Review

Fifth Third Bancorp increased its Transmedics (TMDX) stake by 4,638% in Q1 2026, buying an estimated $2.66M and bringing the position to 20,802 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Fifth Third Bancorp first reported a position in TMDX in Q3 2024 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Fifth Third Bancorp held 20,802 shares of Transmedics worth $2.07M as of Q1 2026.
  • Fifth Third Bancorp bought 20,363 Transmedics shares in Q1 2026, an estimated $2.66M.
  • Transmedics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1201 holding.
  • Fifth Third Bancorp first reported a position in Transmedics in Q3 2024 and has held it in 7 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.